Large-scale screening for somatic mutations in lung cancer von Rosell, Rafael, Karachaliou, Niki

Volltext

Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment von Filipska, Martyna, Rosell, Rafael

Volltext

Activity and safety of brigatinib in ALK -rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial von Gettinger, Scott N, Dr, Bazhenova, Lyudmila A, Prof, Langer, Corey J, Prof, Salgia, Ravi, Prof, Gold, Kathryn A, MD, Rosell, Rafael, Prof, Shaw, Alice T, MD, Weiss, Glen J, MD, Tugnait, Meera, PhD, Narasimhan, Narayana I, PhD, Dorer, David J, PhD, Kerstein, David, MD, Rivera, Victor M, PhD, Clackson, Timothy, PhD, Haluska, Frank G, MD, Camidge, David Ross, Prof

Volltext

Genetics and biomarkers in personalisation of lung cancer treatment von Rosell, Rafael, Dr, Bivona, Trever G, MD, Karachaliou, Niki, MD

Volltext

Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer von Peters, Solange, Camidge, D. Ross, Shaw, Alice T, Gadgeel, Shirish, Ahn, Jin S, Kim, Dong-Wan, Ou, Sai-Hong I, Pérol, Maurice, Dziadziuszko, Rafal, Rosell, Rafael, Zeaiter, Ali, Mitry, Emmanuel, Golding, Sophie, Balas, Bogdana, Noe, Johannes, Morcos, Peter N, Mok, Tony

Volltext

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update von Hanna, Nasser H, Schneider, Bryan J, Temin, Sarah, Baker, Jr, Sherman, Brahmer, Julie, Ellis, Peter M, Gaspar, Laurie E, Haddad, Rami Y, Hesketh, Paul J, Jain, Dharamvir, Jaiyesimi, Ishmael, Johnson, David H, Leighl, Natasha B, Phillips, Tanyanika, Riely, Gregory J, Robinson, Andrew G, Rosell, Rafael, Schiller, Joan H, Singh, Navneet, Spigel, David R, Stabler, Janis O, Tashbar, Joan, Masters, Gregory

Volltext

Implications of Blood-Based T790M Genotyping and Beyond in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer von Rosell, Rafael, Karachaliou, Niki

Volltext

Human endogenous retroviruses and cancer von Gonzalez-Cao, María, Iduma, Paola, Karachaliou, Niki, Santarpia, Mariacarmela, Blanco, Julià, Rosell, Rafael

Volltext

Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival von Lee, Chee Khoon, Davies, Lucy, Wu, Yi-Long, Mitsudomi, Tetsuya, Inoue, Akira, Rosell, Rafael, Zhou, Caicun, Nakagawa, Kazuhiko, Thongprasert, Sumitra, Fukuoka, Masahiro, Lord, Sally, Marschner, Ian, Tu, Yu-Kang, Gralla, Richard J, Gebski, Val, Mok, Tony, Yang, James Chih-Hsin

Volltext

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer von Brambilla, Elisabeth, Le Teuff, Gwénaël, Marguet, Sophie, Lantuejoul, Sylvie, Dunant, Ariane, Graziano, Stephen, Pirker, Robert, Douillard, Jean-Yves, Le Chevalier, Thierry, Filipits, Martin, Rosell, Rafael, Kratzke, Robert, Popper, Helmut, Soria, Jean-Charles, Shepherd, Frances A, Seymour, Lesley, Tsao, Ming Sound

Volltext

Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis von Tian, Yuejun, Ma, Zhiming, Chen, Zhaohui, Li, Mingguo, Wu, Zhiping, Hong, Mei, Wang, Hanzhang, Svatek, Robert, Rodriguez, Ronald, Wang, Zhiping

Volltext

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection von Tsao, Ming-Sound, Marguet, Sophie, Le Teuff, Gwénaël, Lantuejoul, Sylvie, Shepherd, Frances A, Seymour, Lesley, Kratzke, Robert, Graziano, Stephen L, Popper, Helmut H, Rosell, Rafael, Douillard, Jean-Yves, Le-Chevalier, Thierry, Pignon, Jean-Pierre, Soria, Jean-Charles, Brambilla, Elisabeth M

Volltext

SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer von Bell, Erica Hlavin, Chakraborty, Arup R, Mo, Xiaokui, Liu, Ziyan, Shilo, Konstantin, Kirste, Simon, Stegmaier, Petra, McNulty, Maureen, Karachaliou, Niki, Rosell, Rafael, Bepler, Gerold, Carbone, David P, Chakravarti, Arnab

Volltext

Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC) von Moya-Horno, Irene, Viteri, Santiago, Karachaliou, Niki, Rosell, Rafael

Volltext

RE: Reply to Rio-Vilariño and colleagues’ article and misconception about YAP1 Ser 397 phosphorylation function von Rosell, Rafael

Volltext

Targeting MET amplification in EGFR-mutant non-small-cell lung cancer von Rosell, Rafael, Chaib, Imane, Santarpia, Mariacarmela

Volltext

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer von Jacobsen, Kirstine, Bertran-Alamillo, Jordi, Molina, Miguel Angel, Teixidó, Cristina, Karachaliou, Niki, Pedersen, Martin Haar, Castellví, Josep, Garzón, Mónica, Codony-Servat, Carles, Codony-Servat, Jordi, Giménez-Capitán, Ana, Drozdowskyj, Ana, Viteri, Santiago, Larsen, Martin R., Lassen, Ulrik, Felip, Enriqueta, Bivona, Trever G., Ditzel, Henrik J., Rosell, Rafael

Volltext

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer von Zhang, Zhenfeng, Lee, Jae Cheol, Lin, Luping, Olivas, Victor, Au, Valerie, LaFramboise, Thomas, Abdel-Rahman, Mohamed, Wang, Xiaoqi, Levine, Alan D, Rho, Jin Kyung, Choi, Yun Jung, Choi, Chang-Min, Kim, Sang-We, Jang, Se Jin, Park, Young Soo, Kim, Woo Sung, Lee, Dae Ho, Lee, Jung-Shin, Miller, Vincent A, Arcila, Maria, Ladanyi, Marc, Moonsamy, Philicia, Sawyers, Charles, Boggon, Titus J, Ma, Patrick C, Costa, Carlota, Taron, Miquel, Rosell, Rafael, Halmos, Balazs, Bivona, Trever G

Volltext

Clinical assessment of immune-related adverse events von Sosa, Aaron, Lopez Cadena, Esther, Simon Olive, Cristina, Karachaliou, Niki, Rosell, Rafael

Volltext

BRAFV600E and BRAF-inactivating mutations in NSCLC von Rosell, Rafael, Karachaliou, Niki

Volltext